
INTEC is a collaboration between innovative European SMEs Fluicell and Cytocypher, focused on developing an integrated platform for cardiac toxicology and efficacy. The project aims to create next-generation cardiac screening solutions that enhance understanding of cardiac cell behavior and functionality through advanced monitoring techniques and AI-driven analysis. By addressing the lack of predictive human disease models, INTEC seeks to improve drug development efficiency and reduce reliance on animal testing, ultimately leading to more precise evaluations of potential new therapies.

INTEC is a collaboration between innovative European SMEs Fluicell and Cytocypher, focused on developing an integrated platform for cardiac toxicology and efficacy. The project aims to create next-generation cardiac screening solutions that enhance understanding of cardiac cell behavior and functionality through advanced monitoring techniques and AI-driven analysis. By addressing the lack of predictive human disease models, INTEC seeks to improve drug development efficiency and reduce reliance on animal testing, ultimately leading to more precise evaluations of potential new therapies.